Why INVO Fertility Stock Is Surging Friday Afternoon
INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure
INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q
INVO Fertility Announces Fiscal Year 2025 Financial Results
INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K
INVO Fertility Announces a 1:5 Reverse Stock Split Effective Pre-Market Opening on March 27, 2026
Comparing INVO Fertility (NASDAQ:IVF) & Revolutions Medical (OTCMKTS:RMCP)
INVO Fertility, Inc (NASDAQ:IVF) Sees Large Growth in Short Interest
INVO Fertility Announces Availability of Advanced Incubation Technology at its Wisconsin Clinic
INVO Fertility's Wisconsin Clinic Joins Progyny Network
INVO Fertility Closes Acquisition of Indiana-Based Fertility Clinic “Family Beginnings”
INVO Fertility Announces Patent Issuance for Modified INVOcell® Device
INVO Fertility (NASDAQ:IVF) and Minerva Surgical (NASDAQ:UTRS) Head-To-Head Analysis
INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
Comparing Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) & INVO Fertility (NASDAQ:IVF)
INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic “Family Beginnings”
INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic “Family Beginnings”
INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025
INVO Fertility Announces Third Quarter 2025 Financial Results
INVO Fertility Partners with Heidi Health to Bring AI-Powered Tools to INVO's Wisconsin Fertility Institute
INVO Fertility to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
INVO Fertility Announces Second Quarter 2025 Financial Results
INVO Fertility Announces a 1:3 Reverse Stock Split Effective Pre-Market Opening on July 21, 2025
INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing
INVO Fertility Adds Platelet-Rich Plasma Therapy Capabilities at Wisconsin Fertility Institute
INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent
INVO Fertility Reminds Shareholders to Cast Their Vote for Upcoming Annual Meeting of Shareholders to be held on Wednesday, June 25, 2025 at 12:00 p.m. Eastern Time
INVO Fertility Expands Telehealth Capabilities at Its Wisconsin Fertility Institute
INVO Fertility's Wisconsin Clinic Recognized on Newsweek's List of America's Best Fertility Clinics for 2025
INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
INVO Fertility Announces First Quarter 2025 Financial Results
INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”
NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”
NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025
NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment
NAYA Biosciences Announces Nomination of New Board Members
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)